Complement inhibition in paroxysmal nocturnal hemoglobinuria (PNH): a systematic review and expert opinion from central Europe on special patient populations
I Bodó, I Amine, A Boban, H Bumbea, A Kulagin… - Advances in …, 2023 - Springer
Introduction Hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) is complement-
mediated due to the lack of complement inhibitors in the hemopoietic cell membranes …
mediated due to the lack of complement inhibitors in the hemopoietic cell membranes …
[HTML][HTML] Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
J Ilic, B Pujic, B Jakovljevic, B Sekulic, D Agic… - Clinical Case …, 2024 - ncbi.nlm.nih.gov
2. METHODS At the Clinical Centre of Vojvodina, two women with PNH were treated with
eculizumab during pregnancy and postpartum in 2021 and 2022. This mini case series …
eculizumab during pregnancy and postpartum in 2021 and 2022. This mini case series …
[PDF][PDF] Publikacje pracowników i doktorantów UJ CM dodane do bazy PubMed od 1 do 31 marca 2022 r.
J Kużdżał, P Kocoń - Acta Anaesthesiol Scand, 2022 - cm-uj.krakow.pl
8. Łakuta P., Krankowska D., Marcinkiewicz P., Bociąga-Jasik M., Komorska-Błażewicz A.
Enhancing well-being and alleviating depressive symptoms in people with HIV/AIDS: An …
Enhancing well-being and alleviating depressive symptoms in people with HIV/AIDS: An …